← Back to BNGO

Bionano Genomics, Inc. - Common Stock financial statements

Annual and standalone quarterly facts filed by the company with the SEC. Monetary values are shown in USD millions; per-share values use USD.

Filed statements

USD; millions except EPSJun 2026Filed 10/08/2026Mar 2026Filed 10/08/2026Sep 2025Filed 13/11/2025Jun 2025Filed 10/08/2026Mar 2025Filed 10/08/2026Sep 2024Filed 13/11/2025Jun 2024Filed 13/11/2025Mar 2024Filed 13/11/2025
$8.2$6.7$7.4$6.7$6.5$6.1$7.8$8.8
−$7.4−$8.3−$8.5−$6.9−$3.1−$44−$16−$31
−$0.64−$0.76−$1.59−$1.99−$1.15−$30.92−$14.41−$35.75
12115.33.42.7

Trend

Revenue

Source: SEC EDGAR Company Facts. Values are normalized from issuer-filed US GAAP or IFRS XBRL facts. Missing cells stay missing; cumulative interim cash flows are not converted into estimated quarters.